RBGLY IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Reckitt Benckiser Group PLC Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RBGLY

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Reckitt class action, go to https://rosenlegal.com/submit–form/?case_id=40120 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis (“NEC”) by consuming Reckitt’s cow’s milk–based formula, Enfamil; (2) of the attendant impact on Reckitt’s sales of Enfamil and Reckitt’s exposure to legal claims; and (3) as a result of the above, defendants’ positive statements about Reckitt’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Reckitt action, go to https://rosenlegal.com/submit–form/?case_id=40120 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        [email protected]
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9496908)

EB5 Capital’s Aspen Mountain Hotel (JF43) Project Receives I-956F Approval from USCIS

WASHINGTON, July 18, 2025 (GLOBE NEWSWIRE) — EB5 Capital is excited to announce that its Aspen Mountain Hotel (JF43) project was approved by the United States Citizenship and Immigration Services (USCIS) on May 19, 2025, after pending for approximately three months. This Form I–956F approval confirms that USCIS has assessed and verified the compliance of the project and its related documents. Now that the project is approved by USCIS, investors who filed I–526E conditional green card petitions in this project can anticipate receiving individual petition adjudications in the coming months. This marks EB5 Capital’s 14th I–956F approval from USCIS.

Located in a Rural TEA, Aspen Mountain Hotel (JF43) is a redevelopment project in Aspen, Colorado, transforming the iconic Mountain Chalet Aspen into a 59–key luxury hotel. The project will preserve the original chalet’s historic charm while incorporating modern features. Positioned near the center of town and close to the Aspen Mountain Ski Resort, the hotel will offer year–round access to Aspen’s fine dining, shopping, and outdoor activities.

“We are pleased with this quick project approval from USCIS and are especially excited about this project,” said Natalia Pronina, Vice President of Investor Relations at EB5 Capital. “We’ve had the opportunity to experience the improvement in processing times for I–956F applications firsthand and look forward to future approvals.”

To date, EB5 Capital has raised investor funds across over 45 EB–5 projects throughout the United States. JF43 is EB5 Capital’s fourth rural TEA project and third in the state of Colorado.

About EB5 Capital

EB5 Capital provides qualified foreign investors opportunities to invest in job–creating commercial real estate projects under the United States Immigrant Investor Program (EB–5 Visa Program). As one of the country’s oldest and most active Regional Center operators, the firm has raised more than one billion dollars of foreign capital across over 45 EB–5 projects. Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. Please visit www.eb5capital.com for more information.

Contact:

Katherine Willis
Director, Marketing & Communications
[email protected]


GLOBENEWSWIRE (Distribution ID 9496906)